Bandingkan Harga & Kinerja Steady Safe Tbk (SAFE) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Steady Safe Tbk dan Organon Pharma Indonesia Tbk.: Steady Safe Tbk diperdagangkan di Rp875 (kapitalisasi pasar 574,85 M, volume 24 jam 1,59 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Steady Safe Tbk jauh lebih besar — sekitar 5,5× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SAFE | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 574,85 M | 104,4 M |
Volume | 1,59 jt | — |
Lot | 15,86 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Steady Safe Tbk
PT Steady Safe is a major transportation company serving Indonesia and primarily the capital, Jakarta. It was established in 1971 under the name “PT Tanda Widjaja Sakti”. In December 1993, in preparation for the public offering of its shares, the company changed its name to PT Steady Safe. The start-up with a license to operate 150 vehicles as taxis for Jakarta has today become a premier mass transportation company. Steady Safe has introduced the Jakarta’s first privately managed air-conditioned buses. At present, the company operates thirteen Pool and workshops in the Greater Jakarta Area for the logistical and technical support of its taxi and bus fleets. Steady Safe is listed in Jakarta Stock Exchange and the Surabaya Stock Exchange with 213,839,600 shares traded under the stock code SAFE.
Selengkapnya di halaman SAFE →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
